Status of vitamins E and A and ß-carotene and health in organic dairy cows fed a diet without synthetic vitamins.

Synthetic vitamin supplementation is not consistent with organic production, so it is important to investigate whether dairy cows can maintain their health and production without synthetic vitamins being added to their diet. In basic dairy cow diets, provitamin A (ß-carotene) and vitamin E are mainly found in pasture and in grass and legume silages, but the concentrations are highly variable. This study compared the vitamin status and health of cows without synthetic vitamin supplementation (NSV group) with control cows (CON group) fed synthetic vitamins according to Swedish recommendations (600 IU of vitamin E and 80,000 IU of vitamin A per cow per day) to investigate whether dairy cows can fulfill their requirements of vitamins A and E without supplementation with synthetic vitamins. Vitamin concentrations in blood plasma and milk, health, fertility, milk yield, and milk composition were measured in Swedish Holstein cows (n=28) during 2 complete lactations. All cows were fed a 100% organic diet containing grass-legume silage, cold-pressed rapeseed cake, peas, cereal grains, and minerals. Blood samples were collected from each cow 3 wk before expected calving, at calving, and 3 wk, 3 to 5 mo, and 7 to 9 mo after calving. Samples of colostrum were taken and milk samples were collected 4d after calving and at the same time as the 3 blood samplings after calving. The only difference in vitamin status between groups was found in colostrum in yr 1, when CON cows tended to have a higher concentration of α-tocopherol, and their ß-carotene concentration was higher compared with NSV cows. The NSV cows tended to have more cases of mastitis than CON cows in yr 2. Within the NSV group, fewer cows were healthy and more cases of mastitis were observed in yr 2 than in yr 1. The groups did not differ in production parameters. In conclusion, the vitamin status in blood and milk of the studied cows indicated that cows in organic dairy production can fulfill their requirements of vitamins A and E without any supplementation of synthetic vitamins, except at the time around calving, when the requirements are high. However, the impaired health of NSV cows in yr 2 may indicate a long-term negative health effect in cows fed no synthetic vitamins.

Supplementation of RRR-alpha-tocopheryl acetate to periparturient dairy cows in commercial herds with high mastitis incidence.

Dietary vitamin E supplementation of dairy cows around calving has been associated with improved udder health. However, few studies have been performed in Europe and in commercial dairy herds. Therefore, the main aim of the study was to evaluate whether extra daily dietary supplementation of 1,610 mg of alpha-tocopherol, in the form of RRR-alpha-tocopheryl acetate, to dairy cows around calving could improve the udder health in commercial herds with a high incidence of veterinary-treated clinical mastitis. In addition, the effects of supplementation on other cow diseases, fertility, milk production, culling, and stillbirth were also studied. Cows in 21 herds in southeast Sweden were assigned to 1 of 2 groups, 1) daily supplementation with 1,610 mg of RRR-alpha-tocopherol from 4 wk before to 2 wk after calving (n = 196), or 2) no extra supplementation (n = 203), on top of the normal diet containing average vitamin E supplementation (on average, 386, 664, and 957 mg/d to cows at 1 mo prior to calving, at calving, and at 15 d after calving, respectively). Multivariable generalized linear mixed models were used for statistical analyses of the effects of supplementation on the cumulative incidence risk of veterinary-treated clinical mastitis and of veterinary-treated diseases other than mastitis within 1 and 2 mo after calving, culling (due to udder health or other reasons) within 2 and 9 mo after calving, the risk of stillbirth or calf death within 24 h after calving, time from calving to first insemination, number of inseminations per service period, and cow composite natural logarithm of somatic cell count and daily milk production at the first monthly testing after calving. A significant effect of supplementation was observed only for stillbirth or calf death within 24 h after birth, which was significantly lower in the supplemented group. The reasons for this finding require further study.

Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle.

A crude ginseng extract (GS) and the purified ginsenoside R(b1) (R(b1)) were evaluated for their adjuvant effects in dairy cattle at immunisation with ovalbumin (OVA) and/or a Staphylococcus aureus bacterin used for prevention of bovine mastitis. To evaluate a suitable dose of GS as an adjuvant, 36 lactating cows were randomly divided into six groups. The cows were inoculated twice intramuscularly with a 2-week interval, with saline solution, OVA in saline, or OVA in combination with 4, 16 or 64 mg GS, or Al(OH)(3). The level of specific antibodies to OVA in serum and milk whey was measured before immunisations and 1-5 weeks after the second immunisation. The antibody response in serum was significantly higher in animals immunised with OVA and GS than in animals immunised with OVA alone. A significant increase in milk antibody titres compared with OVA only was only found 2 weeks after the second immunisation in the group immunised with OVA and 4 mg GS. In the second part of the study, 18 heifers were randomly divided into three groups and were immunised twice intramuscularly with a two week interval, with the S. aureus bacterin (control), or with the bacterin in combination with 4 mg GS or 1mg R(b1). The specific antibody response to S. aureus and the lymphocyte proliferation after stimulation with PWM, concanavalin A (Con A) or a specific S. aureus antigen was evaluated in blood samples taken before and after immunisations as specified above. Addition of R(b1) resulted both in significantly higher antibody production and lymphocyte proliferation in response to PWM, Con A and S. aureus antigens than in the control group. Addition of GS induced a significantly higher lymphocyte proliferation in response to PWM and Con A than the control, but had no additional effect on the antibody production. In conclusion, both GS and R(b1) were safe adjuvants, and R(b1) had the strongest adjuvant effects, when used for immunisation against S. aureus in dairy cattle. Field trials are warranted to test the ability of GS and R(b1) to enhance the efficacy of mastitis vaccines in protection against intramammary infections.